Financials

  • Market Capitalization 289.77 M
  • Employee 28
  • Founded 2018
  • CEO N/A
  • Website www.opusgtx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BT34Q3
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.47
Relación precio/flujo de caja
25.85

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3347
INDP
Indaptus Therapeutics, Inc. - Common Stock
2.63 USD0.00%+1.54%-30.61%+38.42%297.83 M USD
3366
NMRA
Neumora Therapeutics, Inc. - Common Stock
1.58 USD-1.25%-7.60%+66.32%+3.27%292.75 M USD
3381
TTRX
Turn Therapeutics Inc. - Common Stock
9.64 USD+1.80%+2.77%+47.85%-3.60%287.16 M USD
3396
GLSI
Greenwich LifeSciences, Inc. - Common stock
19.01 USD+2.37%+3.54%-17.49%+87.66%279.03 M USD